Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash $ 6,104,587 $ 10,950,927
Prepaid expenses and other current assets 414,120 554,321
Australia research and development incentives receivable 114,426 302,789
Total current assets 6,633,133 11,808,037
Deferred offering costs 365,140 211,203
Other assets 2,800 2,800
Total assets 7,001,073 12,022,040
Current liabilities:    
Accounts payable 1,226,101 1,165,505
Accrued expenses 2,923,853 2,103,401
Total current liabilities 4,149,954 3,268,906
Long term liabilities:    
Warrant liability 103,407 245,341
Total liabilities 4,253,361 3,514,247
Commitments and contingencies (Note 6)
Stockholders' equity (deficit)    
Preferred stock, $0.0001 par value, 30,000,000 shares authorized at September 30, 2023 and December 31, 2022, 0 shares issued and outstanding
Common stock, $0.0001 par value, 70,000,000 shares authorized at September 30, 2023 and December 31, 2022, 13,761,123 and 10,955,904 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 1,377 1,096
Additional paid-in capital 60,513,616 52,729,942
Accumulated deficit (57,723,515) (44,207,272)
Accumulated other comprehensive loss (43,766) (15,973)
Total stockholders' equity 2,747,712 8,507,793
Total liabilities and stockholders' equity $ 7,001,073 $ 12,022,040